We are committed to finding a cure for WM.

Did you know?

 

Welcome to the Waldenstrom’s Macroglobulinemia Foundation of Canada (WMFC)

If you have been diagnosed with Waldenstrom’s Macroglobulinemia (WM) or care for someone who has, welcome to the WMFC family of WM patients, caregivers, friends and relatives. We are a community providing support, research and information on WM.

Sign up for our newsletter below to receive updated information.

 

Information for the newly diagnosed

Article: Exploring Use of Ibrutinib/Rituximab Combination for Waldenström Macroglobulinemia

Exploring Use of Ibrutinib/Rituximab Combination for Waldenström Macroglobulinemia JULY 06, 2018 Kristi Rosa   Source: Rare Disease Report –  https://www.raredr.com/conferences/asco2018/exploring-use-of-ibrutinib-rituximab-combination-for-waldenstrom-macroglobulinemia   A type of non-Hodgkin lymphoma, Waldenström macroglobulinemia is aRead More

Book Recommendations

  We are compiling a reading list of books that our members have recommended. Please feel free to send us titles that you have found inspiring and resourceful.   HAVERead More

5th International Patient and Physician Summit on Waldenstrom’s Macroglobulinemia (WM)

October 13-14, 2018 New York Marriott Downtown Hotel and Conference Center The Summit is planned in conjunction with the 10th International Workshop on WM (IWWM-10), October 11-13, 2018 where overRead More

FDA Grants Priority Review to Waldenstrom’s Macroglobulinemia Combination Therapy

Source: https://www.raredr.com/news/waldenstroms-macroglobulinemia-combination-therapy-receives-new-drug-designation Pharmacyclics LLC, an AbbVie company, and Janssen Biotech, Inc announced that the US Food and Drug Administration (FDA) has granted Priority Review for a supplemental New Drug ApplicationRead More

Subscribe to our newsletter